Telesis Bio (TBIO) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free TBIO Stock Alerts $4.62 +0.41 (+9.73%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 10, 2024 | marketbeat.comTelesis Bio, Inc. (NASDAQ:TBIO) Short Interest UpdateTelesis Bio, Inc. (NASDAQ:TBIO - Get Free Report) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 3,600 shares, a decrease of 96.6% from the April 15th total of 105,100 shares. Based on an average trading volume of 46,000 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the shares of the company are short sold.May 10, 2024 | investorplace.comTBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q1 2024May 9, 2024 | globenewswire.comTelesis Bio Reports First Quarter 2024 Financial ResultsMay 9, 2024 | marketbeat.comTrading was temporarily halted for "TBIO" at 07:05 PM with a stated reason of "News pending."May 6, 2024 | globenewswire.comTelesis Bio Announces Reverse Stock SplitApril 20, 2024 | uk.investing.comTelesis Bio appoints new CEO as founder steps downApril 18, 2024 | msn.comTelesis Bio announces leadership transition amid new commercial focusApril 18, 2024 | globenewswire.comTelesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadershipMarch 29, 2024 | msn.comTBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023March 28, 2024 | globenewswire.comTelesis Bio Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 3, 2024 | morningstar.comTelesis Bio Inc TBIOFebruary 26, 2024 | finance.yahoo.comTelesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsFebruary 26, 2024 | globenewswire.comTelesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial ResultsFebruary 24, 2024 | benzinga.comTelesis Bio Stock (NASDAQ:TBIO), Insider Trading ActivityFebruary 23, 2024 | investorplace.comWhy Is Telesis Bio (TBIO) Stock Up 29% Today?February 23, 2024 | msn.comToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayFebruary 18, 2024 | finance.yahoo.comTelesis Bio, Inc. (TBIO)February 6, 2024 | finance.yahoo.comTelesis Bio, Inc.'s (NASDAQ:TBIO) Shares Leap 38% Yet They're Still Not Telling The Full StoryFebruary 6, 2024 | finance.yahoo.comBeat the Market the Zacks Way: Hershey's, Telesis Bio, General Mills in FocusFebruary 6, 2024 | finance.yahoo.comTelesis Bio (TBIO) Reports Q1 Loss, Misses Revenue EstimatesFebruary 6, 2024 | finance.yahoo.comTelesis Bio First Quarter 2023 Earnings: EPS Beats Expectations, Revenues LagFebruary 6, 2024 | finance.yahoo.comThis Telesis Bio Insider Increased Their Holding In The Last YearJanuary 22, 2024 | msn.comToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayNovember 13, 2023 | msn.comTelesis Bio GAAP EPS of -$0.37, revenue of $5.6MNovember 13, 2023 | msn.comTelesis Bio GAAP EPS of -$0.37 misses by $0.04, revenue of $5.6M misses by $1.8MAugust 30, 2023 | markets.businessinsider.comTelesis Bio Appoints William Kullback CFOAugust 29, 2023 | seekingalpha.comTelesis Bio appoints William Kullback as CFOAugust 29, 2023 | markets.businessinsider.comTelesis Bio Appoints William J. Kullback Chief Financial OfficerAugust 11, 2023 | markets.businessinsider.comTelesis Bio (TBIO) Receives a Rating Update from a Top AnalystAugust 11, 2023 | msn.comBofA lowers rating on Telesis Bio to sector weight from overweightAugust 11, 2023 | markets.businessinsider.comPfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: AnalystAugust 11, 2023 | sfgate.comTelesis Bio: Q2 Earnings SnapshotJune 24, 2023 | fool.comTelesis Bio (NASDAQ: DNAY)May 12, 2023 | marketbeat.comBlue Bird, First Solar rise; Harrow Health, Telesis Bio fallStocks that traded heavily or had substantial price changes Friday: Blue Bird, First Solar rise; Harrow Health, Telesis Bio fallMay 11, 2023 | investing.comTelesis Bio Inc (TBIO)April 12, 2023 | forbes.comThis Desktop Machine Is About To Transform The Decades-Old DNA Synthesis IndustryMarch 31, 2023 | marketwatch.comTelesis Bio Shares Rise 10% After Release of Two New DNA KitsMarch 22, 2023 | marketwatch.comTelesis Bio Shares Climb 35% on 2023 Revenue GuidanceMarch 21, 2023 | sfgate.comTelesis Bio: Q4 Earnings SnapshotMarch 21, 2023 | finance.yahoo.comTelesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 GuidanceMarch 16, 2023 | msn.comShould You Buy Telesis Bio (TBIO) After Golden Cross?March 14, 2023 | forbes.comSynthetic Biology Startup Molecular Assemblies Ships First DNA From New San Diego FacilityJanuary 3, 2023 | yahoo.comProtalix BioTherapeutics Issues 2023 Letter to StockholdersDecember 14, 2022 | uk.finance.yahoo.comTelesis Bio, Inc. (DNAY)November 21, 2022 | forbes.comCan A Desktop DNA Printer Stomp Out The Next Pandemic?November 12, 2022 | seekingalpha.comTelesis Bio, Inc. (DNAY) Q3 2022 Earnings Call TranscriptNovember 11, 2022 | finance.yahoo.comTelesis Bio, Inc. (NASDAQ:DNAY) Consensus Forecasts Have Become A Little Darker Since Its Latest ReportNovember 8, 2022 | finance.yahoo.comTelesis Bio Inc. Reports Third Quarter 2022 Financial ResultsOctober 19, 2022 | finance.yahoo.comTelesis Bio and Cellibre Announce Collaboration to Optimize Development of Future BioXp® DBC instrumentOctober 4, 2022 | finanznachrichten.deCodex DNA, Inc.: Codex DNA Expands Application of Proprietary Error Correction Technology Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. TBIO Media Mentions By Week TBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TBIO News Sentiment▼0.320.54▲Average Medical News Sentiment TBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TBIO Articles This Week▼70▲TBIO Articles Average Week Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Precipio News Today Talis Biomedical News Today Cue Health News Today Accelerate Diagnostics News Today Singular Genomics Systems News Today Virios Therapeutics News Today AquaBounty Technologies News Today Trevena News Today XWELL News Today TRxADE HEALTH News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TBIO) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
